McGrath J C, O'Brien J W
Br J Pharmacol. 1987 Jun;91(2):355-65. doi: 10.1111/j.1476-5381.1987.tb10290.x.
Nifedipine was tested against pressor responses in the pithed rat to ten agonists with varying selectivity for alpha 1- and alpha 2-adrenoceptors, injected as a bolus or infused intravenously: i.e. amidephrine, azepexole, cirazoline, indanidine, M7, methoxamine, noradrenaline (NA), oxymetazoline, phenylephrine and xylazine. Nifedipine, administered before the agonists, inhibited responses initiated by all agonists, usually for both the bolus and infusion responses. With a bolus, blockade was significantly greater against the more prolonged, secondary components of the pressor responses. This demonstrates that calcium-entry occurs during the secondary component of the alpha-adrenoceptor-mediated response and can be initiated by either alpha 1- or alpha 2-adrenoceptor subtypes. The time courses of responses to infusion varied. Selective alpha 1-adrenoceptor agonists, with the exception of indanidine, did not produce a stable pressor response during the 20 min infusion time but alpha 2-adrenoceptor agonists did. Nifedipine reduced responses to infusion with no preference for alpha 1- or alpha 2-agonists. Phenylephrine and NA produced pressor responses which reached a peak and then declined during the remainder of the infusion. The levels of NA in arterial and venous plasma were measured by h.p.l.c. during the infusion of NA. Arterial NA levels rose throughout the infusion whereas venous levels remained relatively unaffected. The absolute levels of plasma NA suggest that a large proportion of intravenously administered NA is removed in the pulmonary circulation and the remainder is removed in the systemic circulation with negligible recirculation. The consequences of these results, for assessment of the mechanisms of action of adrenoceptor agonists and calcium entry blockers, are discussed.
硝苯地平在去脑大鼠中针对十种对α1和α2肾上腺素能受体具有不同选择性的激动剂的升压反应进行了测试,这些激动剂通过静脉推注或静脉输注给药,即去氧肾上腺素、阿泽哌唑、可乐定、茚达立定、M7、甲氧明、去甲肾上腺素(NA)、羟甲唑啉、去氧肾上腺素和赛拉嗪。在激动剂给药前给予硝苯地平,可抑制所有激动剂引发的反应,通常对推注和输注反应均有效。静脉推注时,对升压反应中持续时间更长的次要成分的阻断作用明显更强。这表明钙内流发生在α肾上腺素能受体介导反应的次要成分期间,并且可以由α1或α2肾上腺素能受体亚型引发。对输注反应的时间进程各不相同。除茚达立定外,选择性α1肾上腺素能受体激动剂在20分钟输注期间未产生稳定的升压反应,但α2肾上腺素能受体激动剂则产生了稳定的升压反应。硝苯地平对α1或α2激动剂的输注反应均有降低作用。去氧肾上腺素和NA产生的升压反应在输注的其余时间达到峰值后下降。在输注NA期间,通过高效液相色谱法测量动脉和静脉血浆中的NA水平。在整个输注过程中,动脉NA水平升高,而静脉水平相对不受影响。血浆NA的绝对水平表明,静脉注射的NA大部分在肺循环中被清除,其余部分在体循环中被清除,再循环可忽略不计。讨论了这些结果对评估肾上腺素能受体激动剂和钙通道阻滞剂作用机制的影响。